Former President Trump has shifted his position on a controversial drug pricing plan that aimed to lower costs by limiting what Medicare paid for prescription drugs. After initially supporting the plan, Trump’s campaign now indicates a move away from it. While still committed to lowering drug costs for Americans, the campaign has backed off the aggressive pricing policy. Instead, Trump’s campaign is proposing increasing transparency, promoting choice and competition, expanding access to affordable healthcare and prescription drug options. The campaign also suggests creating a presidential commission to investigate a rise in chronic illness and banning regulators from taking jobs with the industries they regulate.
Source link
Trump policy on drug pricing: Abandons most favored nations idea
